Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 17 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

41%

7 trials in Phase 3/4

Results Transparency

23%

3 of 13 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

14Total
Not Applicable (4)
P 1 (2)
P 2 (1)
P 3 (2)
P 4 (5)

Trial Status

Completed13
Recruiting3
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 13 completed trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07322913Recruiting

Intervascular Post-Market Clinical Follow-Up (PMCF) Registry

NCT06777901Phase 4RecruitingPrimary

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

NCT05192707RecruitingPrimary

Transcutaneous Oxygen Pressure (TcPO2) Determination.

NCT02041169Not ApplicableCompletedPrimary

Lower Extremity Peripheral Arterial Disease and Exercise Ischemia

NCT03469349Phase 3CompletedPrimary

Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB

NCT02066740Not ApplicableCompletedPrimary

EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study

NCT01983449Phase 4CompletedPrimary

Effectiveness of Adventitial Dexamethasone in Peripheral Artery Disease

NCT02531139Not ApplicableWithdrawn

The Effect of Blood Pressure on Cerebral Perfusion During Vascular Surgery

NCT02920125Phase 3Completed

Study the Result of Ayurvedic SUVED & Reimmugen (Colostrum) Treatment on Vascular Disease, CAD, CVA, DVT.

NCT02273232Phase 1CompletedPrimary

Effects of Remote Ischemic Preconditioning on Moderate PVD Patients A Pilot Randomized Control Trial

NCT01419418CompletedPrimary

Patients' Perspectives of Factors That Support the Management of Peripheral Arterial Disease for Improved Outcomes

NCT01436435Phase 4CompletedPrimary

The Jetstream (JET) Post-market Registry

NCT02786043Phase 1CompletedPrimary

PK Study to Evaluate the Effect of PLC on Healthy Chinese Subjects by Multiple-doses

NCT01952756Phase 4CompletedPrimary

Effect of Cilostazol Endothelial Progenitor Cells and Collateral Formation in Peripheral Occlusive Artery Disease (PAOD)

NCT01336101Not ApplicableCompletedPrimary

Evaluation of Efficacy of the EPIC™ Self-Expanding Nitinol Vascular Stent

NCT00652418Phase 2Completed

Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography

NCT00640770Phase 4CompletedPrimary

Comparing Angioplasty and DES in the Treatment of Subjects With Ischemic Infrapopliteal Arterial Disease

Showing all 17 trials

Research Network

Activity Timeline